The Safety and Effectiveness of Cholinergic Receptor Block Therapy in the Treatment of ALS
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04391361 |
|
Recruitment Status :
Not yet recruiting
First Posted : May 18, 2020
Last Update Posted : October 14, 2020
|
Sponsor:
Ruijin Hospital
Information provided by (Responsible Party):
Ruijin Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Not yet recruiting |
|---|---|
| Estimated Primary Completion Date : | September 30, 2023 |
| Estimated Study Completion Date : | October 31, 2023 |